| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1149 | 2021 |
| Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial E de Jong, JA van Oers, A Beishuizen, P Vos, WJ Vermeijden, LE Haas, ... The Lancet Infectious Diseases 16 (7), 819-827, 2016 | 1001 | 2016 |
| What is antimicrobial stewardship? OJ Dyar, B Huttner, J Schouten, C Pulcini Clinical microbiology and infection 23 (11), 793-798, 2017 | 859 | 2017 |
| Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis EC Schuts, MEJL Hulscher, JW Mouton, CM Verduin, JWTC Stuart, ... The Lancet infectious diseases 16 (7), 847-856, 2016 | 792 | 2016 |
| COVID-19: don't neglect antimicrobial stewardship principles! BD Huttner, G Catho, JR Pano-Pardo, C Pulcini, J Schouten Clinical Microbiology and Infection 26 (7), 808-810, 2020 | 480 | 2020 |
| Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion PE Verweij, BJA Rijnders, RJM Brüggemann, E Azoulay, M Bassetti, ... Intensive care medicine 46 (8), 1524-1535, 2020 | 369 | 2020 |
| Recommendations for antibacterial therapy in adults with COVID-19–an evidence based guideline E Sieswerda, MGJ De Boer, MMJ Bonten, WG Boersma, RE Jonkers, ... Clinical Microbiology and Infection 27 (1), 61-66, 2021 | 265 | 2021 |
| A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit A Tabah, MO Cotta, J Garnacho-Montero, J Schouten, JA Roberts, ... Clinical infectious diseases 62 (8), 1009-1017, 2016 | 239 | 2016 |
| Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial P Pickkers, S Heemskerk, J Schouten, PF Laterre, JL Vincent, ... Critical care 16, 1-12, 2012 | 227 | 2012 |
| Clinical indicators: development and applications H Wollersheim, R Hermens, M Hulscher, J Braspenning, M Ouwens, ... Neth J Med 65 (1), 15-22, 2007 | 214 | 2007 |
| Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project M Bassetti, DR Giacobbe, A Vena, C Trucchi, F Ansaldi, M Antonelli, ... Critical Care 23, 1-7, 2019 | 212 | 2019 |
| Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society … A Tabah, M Bassetti, MH Kollef, JR Zahar, JA Paiva, JF Timsit, JA Roberts, ... Intensive care medicine 46, 245-265, 2020 | 172 | 2020 |
| Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study JA Schouten, MEJL Hulscher, S Natsch, BJ Kullberg, JWM van der Meer, ... BMJ Quality & Safety 16 (2), 143-149, 2007 | 163 | 2007 |
| Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries T Abe, F Madotto, T Pham, I Nagata, M Uchida, N Tamiya, K Kurahashi, ... Critical care 22, 1-16, 2018 | 162 | 2018 |
| Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis PE Verweij, RJM Brüggemann, E Azoulay, M Bassetti, S Blot, JB Buil, ... Intensive care medicine 47 (8), 819-834, 2021 | 149 | 2021 |
| Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure M Stanić Benić, R Milanič, AA Monnier, IC Gyssens, N Adriaenssens, ... Journal of antimicrobial chemotherapy 73 (suppl_6), vi50-vi58, 2018 | 131 | 2018 |
| Factors promoting intensive care patients’ perception of feeling safe: A systematic review A Wassenaar, J Schouten, L Schoonhoven International journal of nursing studies 51 (2), 261-273, 2014 | 131 | 2014 |
| Antibiotic research and development: business as usual? S Harbarth, U Theuretzbacher, J Hackett, Drive-AB Consortium, ... Journal of Antimicrobial Chemotherapy 70 (6), 1604-1607, 2015 | 124 | 2015 |
| Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study JG Laffey, F Madotto, G Bellani, T Pham, E Fan, L Brochard, P Amin, ... The Lancet Respiratory Medicine 5 (8), 627-638, 2017 | 123 | 2017 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 121 | 2023 |